Abstract: A method and system for determining the state of a patients brain under anesthesia. The present invention recognizes that anesthesia compounds induce different signatures in physiological characteristics of the patient under anesthesia and aids interpretation of physiological characteristics and signatures therein based on a selected anesthesia compound. The present invention aids the monitoring and/or interpreting of the physiological characteristics to a state of the patient's brain.

Abstract: Systems and methods of the present disclosure are directed to neural stimulation via audio and visual stimulations. The combination and/or sequence of audio and visual brain stimulations can adjust, control or otherwise manage the frequency of the neural oscillations to provide beneficial effects to one or more cognitive states or cognitive functions of the brain, while mitigating or preventing adverse consequences on a cognitive state or cognitive function that stems from sleep deprivation. In doing so, the present systems and methods can reduce sleep fragmentation, improve sleep quality, and slow the progression of cognitive decline in a subject with Alzheimer's disease and MCI.

Abstract: Systems and methods of the present disclosure are directed to neural stimulation via non-invasive sensory stimulation. Non-invasive sensory stimulations can comprise audio stimulation, visual stimulation, mechanical stimulation, or a combination thereof. The combination and/or sequence of one or more of audio, visual, and mechanical brain stimulations can adjust, control or otherwise manage the frequency of the neural oscillations to provide beneficial effects to one or more cognitive states or cognitive functions of the brain, while mitigating or preventing adverse consequences on a cognitive state or cognitive function that stems from, for example, sleep deprivation, stress, hormonal imbalance, or other physical, physiological, or psychological conditions. In doing so, the present systems and methods can improve the cognitive potential of a person.

Abstract: The present disclosure describes a method for neuromodulating a subject, comprising providing (i) a cognitively engaging content, and (ii) a gamma oscillation inducing waveform, wherein said gamma oscillation inducing waveform: comprises an intensity that renders said gamma oscillation inducing waveform imperceptible to said subject; and causes a therapeutic improvement in a cognitive function, thereby neuromodulating said subject.

Abstract: Systems and methods of the present disclosure are directed to neural stimulation via non-invasive sensory stimuli. The non-invasive sensory stimuli can reduce neuroinflammation, improving synaptic plasticity and stimulating neural networking, and improving microglial-mediated clearance of cerebral insults, which would otherwise contribute to the progression of brain atrophy, by inducing synchronized gamma oscillations in at least one region of a brain in a subject. Stimulations can adjust, control or otherwise manage the frequency of the neural oscillations to provide beneficial effects to one or more cognitive states or cognitive functions of the brain, while mitigating or preventing adverse consequences on a cognitive state or cognitive function that stem from progression of brain atrophy.

Abstract: A head mounted display (HMD) system includes an HMD device worn on a head of a user. The HMD device incorporates electroencephalography (EEG) interfaces for monitoring the brain of a human subject during interaction with the HMD device. Fluctuations in electrical potential that are observed via the EEG interfaces may be used to detect event-related potentials (ERPs). The HMD system may programmatically perform one or more operations in response to detecting ERPs. The HMD system may further include off-board devices that communicate with the HMD device over a wireless communications network.

Abstract: A head-mounted display (HMD) system includes an HMD device worn on a head of a user. The HMD device incorporates electroencephalography (EEG) interfaces for monitoring the brain of the human subject during interaction with the HMD device. Fluctuations in electrical potential that are observed via the EEG interfaces may be used to detect event-related potentials (ERPs). The HMD system may programmatically perform one or more operations in response to detecting ERPs.

Abstract: A method and system for determining the state of a patients brain under anesthesia. The present invention recognizes that anesthesia compounds induce different signatures in physiological characteristics of the patient under anesthesia and aids interpretation of physiological characteristics and signatures therein based on a selected anesthesia compound. The present invention aids the monitoring and/or interpreting of the physiological characteristics to a state of the patient's brain.

Abstract: A head-mounted display (HMD) system includes an HMD device worn on a head of a user. The HMD device incorporates electroencephalography (EEG) interfaces for monitoring the brain of the human subject during interaction with the HMD device. Fluctuations in electrical potential that are observed via the EEG interfaces may be used to detect event-related potentials (ERPs). The HMD system may programmatically perform one or more operations in response to detecting ERPs.

Abstract: A head mounted display (HMD) system includes an HMD device worn on a head of a user. The HMD device incorporates electroencephalography (EEG) interfaces for monitoring the brain of a human subject during interaction with the HMD device. Fluctuations in electrical potential that are observed via the EEG interfaces may be used to detect event-related potentials (ERPs). The HMD system may programmatically perform one or more operations in response to detecting ERPs. The HMD system may further include off-board devices that communicate with the HMD device over a wireless communications network.

Abstract: A method and system for determining the state of a patients brain under anesthesia. The present invention recognizes that anesthesia compounds induce different signatures in physiological characteristics of the patient under anesthesia and aids interpretation of physiological characteristics and signatures therein based on a selected anesthesia compound. The present invention aids the monitoring and/or interpreting of the physiological characteristics to a state of the patient's brain.